Curriculum Vitae

Transcriptie

1 Curriculum Vitae Tara van de Water werd geboren op 16 juli 1981 in Bombay, te India. Zij groeide op in het dorpje Ten Boer in de provincie Groningen, en haalde haar VWO-diploma in 1999 aan het H.N. Werkman-College te Groningen. In 2000 startte zij met de studie Technische Natuurkunde aan de Rijksuniversiteit Groningen. Ze koos voor de specialisatierichting Biomedische Technologie. Het afstudeeronderzoek vond plaats op de afdeling Biomedical Engineering van het Universitair Medisch Centrum Groningen (UMCG). Daar evalueerde ze een wiskundig model voor de beschrijving van de relatie tussen autofluorescentie-metingen en huidskleur. Haar stage-onderzoek deed zij ook in het UMCG, maar dan op de afdeling Radiotherapie. Het doel van dit onderzoek was het evalueren van intensiteitsgemoduleerde radiotherapieplannen voor hoofd-halstumoren. In 2005 studeerde zij af, waarna zij in 2006 startte met haar promotieonderzoek op de afdeling Radiotherapie van het UMCG. Dit onderzoek vond deels plaats in het Centrum voor Protonentherapie op het Paul Scherrer Institute, in Villigen, te Zwitserland. De resultaten van het onderzoek zijn in dit proefschrift beschreven. Sinds juli 2010 is Tara in het UMCG, op de afdeling Radiotherapie, in opleiding tot klinisch fysicus

2 List of publications List of publications Papers - van der Laan HP, van de Water TA, van Herpt H, ChristianenME, Bijl HP, Korevaar EW, Rasch CR, van t Veld AA, van der Schaaf A, Schilstra C, Langendijk JA, on behalf of the Rococo cooperative group. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study. Acta Oncol 2012; Epub ahead of print. - van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland sparing in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2012; 82:e Christianen ME, Langendijk JA. Westerlaan HE, van de Water TA, Bijl HP. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol 2011; 101: van de Water TA, Bijl HP, Schilstra C, Pijls-Johannesma M, Langendijk JA. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. Oncologist 2011;16: van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, Langendijk JA. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011; 79: van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol 2009; 93: van de Water T, van de Water H, Bukman C. A balanced team generating model. European Journal of operational research 2007;180: Mulder DJ, van de Water T, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes technology and therapeutics 2006;8:

3 List of publications Conference contributions - van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA. Intensitymodulated proton therapy with a reduced spot size improves salivary gland-sparing in oropharynx cancer. 11 th Biennial ESTRO meeting on Physics and Radiation Technology, London, UK, May 8-12, van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Schilstra C, Langendijk JA, on behalf of the ROCOCO Group. Dysphagia reduction with optimized photon and proton intensity-modulated radiotherapy for head and neck cancer patients. 11 th Biennial ESTRO meeting on Physics and Radiation Technology, London, UK, May 8-12, van Herpt H, van de Water TA, van der Laan HP, Schilstra C, van der Hulst P, Langendijk JA, van t Veld. Impact of systematic alignment errors in spot-scanned intensity-modulated proton therapy for head and neck cancer. 11 th Biennial ESTRO meeting on Physics and Radiation Technology, London, UK, May 8-12, van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA. Sparing the salivary glands with scanned protons in head and neck radiotherapy: Benefits of 6-field Intensity-Modulated Proton Therapy (IMPT) as compared to 3-field IMPT, PTCOG 48, Heidelberg, Germany, September 31 - Oktober 3, van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA, Comparative treatment planning study between scanned Intensity-Modulated Proton Therapy and Photon Therapy in complex oropharyngeal carcinoma. ESTRO 27 meeting, Göteborg, September 14-18, Jongen R, Dekker A, Qamhiyeh S, Baumert BG, De Neve W, De Meerleer G, De Ruysscher D, Eble M, Engelsman M, Fonteyne V, Habrand JL, Kanematsu N, Langendijk JA, Lomax T, Madani I, Masayuki B, Matsufuji N, Mazal A, Oelfke U, Schlegel W, Tsujii H, Verheij M, Rasch CR, van de Water T, Lambin P. International multicentric in silico clinical trial in lung, prostate and head & neck cancer, comparing photons, protons and C-ion therapy treatment: a multicentric planning study based on a reference dataset of patients: Evaluation of feasibility. ESTRO 27 meeting, Göteborg, September 14-18, van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA. Comparative treatment planning study between scanned Intensity-Modulated Proton

4 List of publications therapy and Photon Therapy in complex oropharyngeal carcinoma. PTCOG 47, Jacksonville, Florida, USA, May 19-24,

5 List of abbreviations List of abbreviations 3B-IMPT 3D-CPT 3D-CRT 6B-SFIMPT CI CT CTCAE CTV CVZ Dmax Dmean Dx % DGT-IMPT dimrt DMPO DVH DVO EIM EUD GTV Gy Gy(RBE) HI HNC HT IGRT IMPT IMRT ISPC study LET MLC MRI Three-beam IMPT Three-dimensional conformal proton therapy Three-dimensional conformal radiotherapy Six-beam split-field IMPT Conformity index or Confidence interval Computed tomography Common toxicity criteria for adverse effects Clinical target volume College voor zorgverzekeringen Maximum dose Mean dose Dose level at which the cumulative DVH intersects with x% of the volume (x % of the volume receives at least this dose level) Distal gradient tracking IMPT Dynamic IMRT Direct machine parameter optimization Dose-volume histogram Dose-volume objective Oesophagus inlet muscle Equivalent uniform dose Gross tumour volume Gray Gray equivalent Heterogeneity index Head and neck cancer Helical tomotherapy Image-guided radiotherapy Intensity-modulated proton therapy Intensity-modulated radiotherapy with photons In silico planning comparative study Linear energy transfer Multi-leaf collimator Magnetic resonance imaging

6 List of abbreviations NTCP NTV OAR PCM PET PG PSI PTV QOL RBE RCT rsimpt RTOG SD SEQ SIB SOBP SPOS ST-IMPT ST-IMRT SW-IMPT SW-IMRT SWOAR (TD)x% TPS UMCG Vx Gy Vx % VF Normal tissue complication probability Normal tissue volume Organ at risk Pharyngeal constrictor muscle Positron emission tomography Prompt gamma Paul Scherrer Institute Planning target volume Quality of life Relative biological effectiveness Randomized controlled trial IMPT with a reduced spot size Radiation therapy oncology group Standard deviation Sequential Simultaneous integrated boost Spread-out Bragg peak Sequential prospective observational studies Standard IMPT Standard IMRT Swallowing-sparing IMPT Swallowing-sparing IMRT Swallowing organ at risk Total dose causing x% toxicity Treatment planning system University Medical Center Groningen Volume receiving x Gy of the prescribed dose Volume receiving x % of the prescribed dose Video fluoroscopy